4.7 Article

KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection

Journal

PLOS PATHOGENS
Volume 7, Issue 10, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.1002270

Keywords

-

Funding

  1. Wellcome Trust
  2. Medical Research Council
  3. National Institutes of Health
  4. National Cancer Institute, National Institutes of Health [HHSN261200800001E]
  5. NIH, National Cancer Institute, Center for Cancer Research
  6. National Institutes of Health, National Institute of Child Health and Human Development [1 R01 HD41224]
  7. National Institute on Drug Abuse [R01-DA-04334, R01-DA-12568, R01-DA-16078]
  8. Medical Research Council [G0601072] Funding Source: researchfish
  9. MRC [G0601072] Funding Source: UKRI

Ask authors/readers for more resources

Killer cell immunoglobulin-like receptors (KIRs) influence both innate and adaptive immunity. But while the role of KIRs in NK-mediated innate immunity is well-documented, the impact of KIRs on the T cell response in human disease is not known. Here we test the hypothesis that an individual's KIR genotype affects the efficiency of their HLA class I-mediated antiviral immune response and the outcome of viral infection. We show that, in two unrelated viral infections, hepatitis C virus and human T lymphotropic virus type 1, possession of the KIR2DL2 gene enhanced both protective and detrimental HLA class I-restricted anti-viral immunity. These results reveal a novel role for inhibitory KIRs. We conclude that inhibitory KIRs, in synergy with T cells, are a major determinant of the outcome of persistent viral infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available